Geneva, June 4 -- International Clinical Trials Registry received information related to the study (ISRCTN16864220) titled 'Quetiapine effectiveness study in borderline personality disorder (QUEST)' on May 20.

Study Type: Interventional

Study Design: Interventional double blind randomized parallel group placebo controlled trial (Safety, Efficacy)

Primary Sponsor: University of Liverpool

Condition: Borderline personality disorder Mental and Behavioural Disorders

Intervention: Participants will be randomised (ratio 1:1) via a secure, 24-hour, web-based randomisation system controlled centrally by the LCTC to receive either quetiapine or matched placebo. Route of administration: oral IMP: Quetiapine prolonged release tablets (over...